Visualization of the Biliary Tract Using Gadobenate Dimeglumine
Authors:
- Fatma Bilge ErgenFEFatma Bilge Ergen
- Deniz AkataDADeniz Akata
- Basar SarikayaBSBasar Sarikaya
- Ulku KerimogluUKUlku Kerimoglu
- Mutlu HayranMHMutlu Hayran
- Okan AkhanOAOkan Akhan
- Hero K. HussainHHHero K. Hussain
- 1 January 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 32 (1) , 54-60
Abstract
To compare contrast-enhanced magnetic resonance (MR) cholangiography (CE-MRC) performed with gadobenate dimeglumine with T2-weighted MRC (T2-MRC) for visualization of the bile ducts in nondilated biliary systems. Twenty consecutive patients who underwent MR imaging (MRI) of the liver and pancreas with nondilated intrahepatic ducts were included in this retrospective study. T2-weighted MRC was performed using a multislice, high-resolution fat-suppressed half-Fourier acquisition turbo spin-echo sequence. Contrast-enhanced MR cholangiography was performed using a fat-suppressed 3-dimensional fast low-angle shot sequence acquired 1 to 1.5 hour after intravenous administration of gadobenate dimeglumine. For image interpretation, the biliary system was divided into 8 segments. Two readers graded visualization of each segment on T2-MRC and CE-MRC using a 5-point scale (0, nonvisualization; 4, excellent visualization). Final opinion for each sequence was rendered by consensus. Superiority of visualization was assessed using the McNemar test and comparing adequately (visualization scores 3 and 4) and inadequately (visualization scores 0, 1, and 2) visualized segments of the ducts on both sequences. Interobserver variability was assessed with kappa statistics. Overall and segment-based evaluation revealed superior visualization of biliary segments with CE-MRC compared with T2-MRC. We also found a statistically significant difference between the 2 sequences for overall and for right hepatic duct and cystic channel visualization (P < 0.05). A high concordance between readers 1 and 2 both for T2-MRC and CE-MRC was achieved (85.8% and 89.4%, respectively). Gadobenate dimeglumine can be used as an alternative intrabiliary contrast agent for contrast-enhanced MR cholangiography in nondilated biliary systems in patients with normal excretory liver function tests.Keywords
This publication has 22 references indexed in Scilit:
- Quantification of Gd-BOPTA Uptake and Biliary Excretion From Dynamic Magnetic Resonance Imaging in Rat LiversInvestigative Radiology, 2005
- Preoperative MRI of Potential Living-Donor-Related Liver Transplantation Using a Single Dose of Gadobenate DimeglumineAmerican Journal of Roentgenology, 2005
- Gadobenate Dimeglumine as an Intrabiliary Contrast Agent: Comparison with Mangafodipir Trisodium with Respect to Non-dilated Biliary Tree DepictionKorean Journal of Radiology, 2005
- Early Biliary Complications of Laparoscopic Cholecystectomy: Evaluation on T2-Weighted MR Cholangiography in Conjunction with Mangafodipir Trisodium-Enhanced T1-Weighted MR CholangiographyAmerican Journal of Roentgenology, 2004
- Functional magnetic resonance cholangiography (fMRC) of the gallbladder and biliary tree with contrast‐enhanced magnetic resonance cholangiographyJournal of Magnetic Resonance Imaging, 2003
- Intrahepatic Biliary Anatomy of Living Adult Liver Donors: Correlation of Mangafodipir Trisodium—Enhanced MR Cholangiography and Intraoperative CholangiographyAmerican Journal of Roentgenology, 2002
- Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid as an Intrabiliary Contrast Agent: Preliminary AssessmentAmerican Journal of Roentgenology, 2002
- Gadolinium Chelates with Weak Binding to Serum ProteinsInvestigative Radiology, 1997
- In vitro and clinical studies of image acquisition in breath-hold MR cholangiopancreatography: single-shot projection technique versus multislice technique.American Journal of Roentgenology, 1997
- Hepatic transport of gadobenate dimeglumine in TR− ratsAcademic Radiology, 1996